Potential antitumor agents. 53. Synthesis, DNA binding properties, and biological activity of perimidines designed as minimal DNA-intercalating agents
- 1 November 1987
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 30 (11) , 2081-2086
- https://doi.org/10.1021/jm00394a025
Abstract
A series of compounds based on perimidine have been synthesized and evaluated for their DNA-binding properties and antitumor activity. The fused tricyclic perimidine chromophore appears to be the minimal structural requirement for intercalative binding to DNA since the mode of binding could be dictated by the position of attachment of the side chain. The intercalating compounds have DNA association constants (log K = 5.8-6.5) and cytotoxic potencies (IC50=500-1500 nM) comparable to those shown by other classes of linear, tricyclic DNA-intercalating antitumor agents (acridinecarboxamides, phenazinecarboxamides), but none of the compounds showed in vivo activity.This publication has 5 references indexed in Scilit:
- Relationships between DNA-binding kinetics and biological activity for the 9-aminoacridine-4-carboxamide class of antitumor agentsJournal of Medicinal Chemistry, 1987
- A substituent constant analysis of the interaction of substituted naphthalene monoimides with DNAJournal of Medicinal Chemistry, 1984
- Interactions of antitumor drugs with natural DNA: proton NMR study of binding mode and kineticsJournal of Medicinal Chemistry, 1984
- Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acidsBiochemical Pharmacology, 1981
- Synthesis of potential antineoplastic agents. XI. Some 2‐aryl‐2,3‐dihydro‐1h‐perimidines and a perimidine mustardJournal of Heterocyclic Chemistry, 1964